4
Changes in Ownership
Arcus Biosciences, Inc. Filed Acc 0001771961-25-000009
Chief Accounting Officer sold 1,900 shares at $26.00 ($49,400)
- Chief Accounting Officer acquired 1,900 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Azoy Alexander · Chief Accounting Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-11-26 | Exercise or conversion : show line 1 in the form 10b5-1 | +1,900 | $13.33 | $25,327 | 29,263 | D |
| 2025-11-26 | Sale : show line 2 in the form 10b5-1 | −1,900 | $26.00 | $49,400 | 27,363 | D |
| Open-market sales · 1,900 sh · avg $26.00 · $49,400 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-11-26 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) | −1,900 | 9,500 | D |
Loading xslF345X05/wk-form4_1764630580.xml…